UK's Health and Safety Exective (HSE) will present views on what works well and what needs to be improved, in the following areas: 1) EU review programme and new active substances – under Directive 91/414 then the renewal programme under Regulation 1107/2009 – numbers, timelines and co-operation between countries; 2) Novel approaches to meet the needs of industry - phased submissions, the co-rapporteur approach and being flexible from peer review to partial evaluations; and 3) Mutual recognition and related processes for product authorisations – how the problems of process and lack of harmonised approaches are tackled.  Based on HSE's experience, recommendations to assist with the GJR process will be discussed.

UK experience on joint reviews

256th National Meeting (2018)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.